Company Info
Phone(905) 629-4222
Year Established
2018
Ticker
NVO
Exchange
NYSE
Contacts
Doug LangaPresident
Steve Benz
General Counsel
Ulrich Otte
Senior VP, Finance & Operations
Blandine Lacroix
Senior VP, BioPharm & Strategy
Steve Albers
Senior VP, Market Access & Public Affairs
Jill Fallows Macaluso
VP, Chief Compliance Officer
Company Description
Novo Nordisk is focused on stem cell research for improved treatment of type 1 diabetes and for future treatments with cell transplantation therapy.
